These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34325635)

  • 1. Construction of Gambogic Acid HPMA Copolymer Coupling Drug System and Study on Anti-tumor Activity.
    Zhao X; Ding S; Li S; Wang Y; Jiang M; Liu J; Chen Y
    Curr Drug Deliv; 2022; 19(4):491-507. PubMed ID: 34325635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
    Li L; Yang Q; Zhou Z; Zhong J; Huang Y
    Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
    Line BR; Mitra A; Nan A; Ghandehari H
    J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
    Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
    J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term biodistribution study of HPMA-ran-LMA copolymers in vivo by means of
    Wagener K; Moderegger D; Allmeroth M; Reibel A; Kramer S; Biesalski B; Bausbacher N; Zentel R; Thews O; Rösch F
    Nucl Med Biol; 2018 Mar; 58():59-66. PubMed ID: 29413458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of anticancer therapeutic efficacy of HPMA copolymer doxorubicin conjugates via combination of ligand modification and stimuli-response srategies.
    Li L; Zhou M; Huang Y
    Int J Pharm; 2018 Jan; 536(1):450-458. PubMed ID: 29237570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancer.
    Chandran SS; Nan A; Rosen DM; Ghandehari H; Denmeade SR
    Mol Cancer Ther; 2007 Nov; 6(11):2928-37. PubMed ID: 18025277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers.
    Fan W; Zhang W; Jia Y; Brusnahan SK; Garrison JC
    Mol Pharm; 2017 May; 14(5):1405-1417. PubMed ID: 28263073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
    Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13.
    Kovár M; Strohalm J; Ulbrich K; Ríhová B
    J Drug Target; 2002 Feb; 10(1):23-30. PubMed ID: 11996083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
    Zhou Z; Li L; Yang Y; Xu X; Huang Y
    Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer.
    Fan W; Shi W; Zhang W; Jia Y; Zhou Z; Brusnahan SK; Garrison JC
    Biomaterials; 2016 Oct; 103():101-115. PubMed ID: 27372424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
    Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD
    Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
    Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
    Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cells of the immune system: mannosylated HPMA-LMA block-copolymer micelles for targeting of dendritic cells.
    Mohr N; Kappel C; Kramer S; Bros M; Grabbe S; Zentel R
    Nanomedicine (Lond); 2016 Oct; 11(20):2679-2697. PubMed ID: 27628185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.